{
    "nctId": "NCT00123669",
    "briefTitle": "Primary Progesterone Therapy for Operable Breast Cancer",
    "officialTitle": "The Primary Progesterone Therapy for Operable Breast Cancer : A Randomized Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 1000,
    "primaryOutcomeMeasure": "To test the effect of primary progesterone in operable breast cancer on overall and disease free survival at 5 years",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Unilateral operable palpable breast cancer\n\nExclusion Criteria:\n\n* Previous history of excision biopsy of the primary tumour\n* History of other epithelial/mesenchymal malignant tumours except basal cell carcinoma/squamous cell carcinoma (BCC/SCC) of skin",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}